Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Inventory (2016 - 2025)

Historic Inventory for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $1.6 million.

  • International Stem Cell's Inventory rose 1495.66% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 1495.66%. This contributed to the annual value of $1.1 million for FY2024, which is 902.61% down from last year.
  • According to the latest figures from Q3 2025, International Stem Cell's Inventory is $1.6 million, which was up 1495.66% from $1.5 million recorded in Q2 2025.
  • International Stem Cell's Inventory's 5-year high stood at $1.6 million during Q3 2025, with a 5-year trough of $1.1 million in Q1 2021.
  • Its 5-year average for Inventory is $1.3 million, with a median of $1.3 million in 2023.
  • In the last 5 years, International Stem Cell's Inventory soared by 2911.67% in 2021 and then crashed by 902.61% in 2024.
  • Quarter analysis of 5 years shows International Stem Cell's Inventory stood at $1.2 million in 2021, then grew by 16.89% to $1.4 million in 2022, then decreased by 8.74% to $1.3 million in 2023, then decreased by 9.03% to $1.1 million in 2024, then surged by 38.47% to $1.6 million in 2025.
  • Its Inventory stands at $1.6 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.3 million for Q1 2025.